Your browser doesn't support javascript.
loading
Intraprocedural assessment of mitral regurgitation during the mitraclip procedure: Impact of continuous left atrial pressure monitoring.
Horstkotte, Jan; Kloeser, C; Beucher, H; Schwarzlaender, E; von Bardeleben, R S; Boekstegers, P.
Afiliação
  • Horstkotte J; Department of Cardiology, Heart Center Siegburg, Helios Klinikum Siegburg, Germany.
  • Kloeser C; Department of Cardiology, Heart Center Siegburg, Helios Klinikum Siegburg, Germany.
  • Beucher H; Department of Cardiology, Heart Center Siegburg, Helios Klinikum Siegburg, Germany.
  • Schwarzlaender E; Department of Cardiology, Heart Center Siegburg, Helios Klinikum Siegburg, Germany.
  • von Bardeleben RS; 2nd Medical Department, Center for Cardiology, University Hospital Mainz, Mainz, Germany.
  • Boekstegers P; Department of Cardiology, Heart Center Siegburg, Helios Klinikum Siegburg, Germany.
Catheter Cardiovasc Interv ; 88(7): 1134-1143, 2016 Dec.
Article em En | MEDLINE | ID: mdl-27038227
ABSTRACT

INTRODUCTION:

Intraprocedural assessment of mitral regurgitation (MR) is a challenging issue during the MitraClip procedure, which might influence not only the position but also the number of MitraClips implanted. Though transesophageal echocardiography (TEE) is the predominant tool used during the MitraClip procedure, MR assessment might be facilitated by a multimodality approach including continuous and simultaneous determination of left atrial and left ventricular (LV) pressure.

METHODS:

86 consecutive patients (76.5 ± 8 years) who qualified for the MitraClip procedure were included into the study. In all patients, the multimodal assessment of MR (TEE, LV angiogram, TEE bubble evaluation, left atrial (LA) pressure => MitraScore) was performed after introducing the MitraClip guide catheter. In the first 42 patients (group A, no CAP), left atrial (LA) pressure (peak pressure of V-wave) was determined only before and after MitraClip implantation, whereas, in the subsequent 44 patients (group B, with CAP), continuous left atrial pressure monitoring (CAP) was performed.

RESULTS:

Patients with CAP (group B) had similar total procedural durations and no increase in the complication rate. MitraScore decreased from 10.5 to 3.5 in group A compared to 10.7 to *2.8 in group B (*P = 0.021 vs. group B). Whether the significant improvement of intraprocedural MR in group B translated into superior MR reduction in the conscious patient, was analyzed by transthoracic echocardiography (TTE) in a blinded fashion. Again MR reduction was significantly greater (P = 0.03) in group B (MR grade 2.8 to 0.9) as compared to group A (MR grade 2.8 to 1.3) and 2D vena contracta decreased from 0.54 ± 0.15 cm to 0.17 ± 0.10 in group B compared to group A (0.56 ± 0.19 cm to *0.23 ± 0.12; *P = 0.01 vs. group B).

CONCLUSIONS:

Multimodality assessment of intraprocedural MR supported by continuous left atrial pressure monitoring was associated with superior intraprocedural results translating into improved MR reduction also at the end of the hospital stay. © 2016 Wiley Periodicals, Inc.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cateterismo Cardíaco / Função do Átrio Esquerdo / Pressão Atrial / Valva Mitral / Insuficiência da Valva Mitral / Monitorização Fisiológica Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cateterismo Cardíaco / Função do Átrio Esquerdo / Pressão Atrial / Valva Mitral / Insuficiência da Valva Mitral / Monitorização Fisiológica Idioma: En Ano de publicação: 2016 Tipo de documento: Article